Chronicle Journal: Finance

AstraZeneca denies its vaccine is less efficient in the elderly; battles with EU over supplies

British-Swedish vaccine maker AstraZeneca is fighting battles on several fronts this week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.